Skip to main content
Bascom Palmer Eye Institute
   HOME EN ESPAÑOL
ADULT EYE TUMORS-
Anatomy of the Eye-
Eye Tumors-
Diagnosis-
Treatment-
Frequently Asked Questions-
Research-
Resources-
Tips for Low-Vision Users-
Contact Us-
RETINOBLASTOMA-
Anatomy of the Eye-
Diagnosis-
Examination Under Anesthesia-
Treatment-
Prosthesis-
Coping with Cancer-
Photogallery-
In the News-
Resources-
About Us-
PRINT VERSION (PDF)



 


The Ocular Oncology service at Bascom Palmer Eye Institute is dedicated to helping you and your family cope effectively from the time of the initial diagnosis of eye cancer through treatment and the follow-up period.

Because eye tumors are so rare, patients may have to travel long distances to seek expert opinion and treatment from an ophthalmologist who specializes in the diagnosis and management of eye cancer. Patients travel from all regions of the United States and from around the world because of Dr. Timothy Murray's years of experience in treating eye tumors, his international reputation, and his excellence in professional and compassionate patient care.

Bascom Palmer Eye Institute of the University of Miami School of Medicine is recognized throughout the world as a leading center for ophthalmic care, research and education. Its full-time faculty of internationally respected physicians and scientists encompasses every ophthalmic subspecialty and, through the years, has contributed fresh insight and direction to many of today's advanced ophthalmic techniques, diagnoses and treatments. Consequently, the facility has been rated one of the best eye hospitals in the nation for 12 consecutive years based on a survey of board-certified ophthalmologists conducted by U.S. News & World Report.

The information on this site is intended to help patients and their families better understand a diagnosis of eye cancer and prepare for treatment. The information presented is for educational purposes only and should not be relied upon as medical advice.

Adult Eye Tumor Information | Retinoblastoma Information

 

National Retinoblastoma Research & Support Foundation